Immunotherapy cancer drugs can cause a potentially vision-robbing side effect. In a new report, Michigan Medicine experts discuss the risks and what oncologists should know.
Medication for diabetic eye disease is crucial, but it’s hard to tell in advance when and how often patients might need it. New research aims to provide insight.
Ocular surgeries are steadily shifting away from hospitals, a move that offers convenience and financial perks. But questions of safety and accessibility remain.
An analysis of Medicare Part D data reveals that a preference among eye care providers for name-brand medication has systemwide cost implications.
A study drug safely minimizes severity for those with a painful eye condition, a new clinical trial at the University of Michigan Kellogg Eye Center has found.